Plexin A1 signaling confers malignant phenotypes in lung cancer cells

Published on Nov 4, 2016in Biochemical and Biophysical Research Communications2.985
· DOI :10.1016/J.BBRC.2016.10.006
Daisuke Yamada7
Estimated H-index: 7
(Niigata University of Pharmacy and Applied Life Sciences),
Satoshi Watanabe1
Estimated H-index: 1
(Niigata University of Pharmacy and Applied Life Sciences)
+ 1 AuthorsTakehiko Maeda20
Estimated H-index: 20
(Niigata University of Pharmacy and Applied Life Sciences)
Sources
Abstract
Abstract Aberrant changes to several signaling pathways because of genetic mutations or increased cytokine production are critical for tumor cells to become malignant. Semaphorin 3A (SEMA3A) acts as a bivalent factor that suppresses or promotes tumor development in different pathological backgrounds. Previously, we showed that SEMA3A positively regulated the proliferative and glycolytic activities of mouse-derived Lewis lung carcinoma (LLC) cells. Plexins A1-A4 (PLXNA1-PLXNA4) are SEMA3A receptors; however, it is not known which subtype is critical for oncogenic SEMA3A signaling. We used LLC cells to investigate the role of PLXNA1 in oncogenic SEMA3A signaling. Using short hairpin RNA-mediated knockdown, we investigated the effects of constitutive inhibition of Plxna1 on cell proliferation, metabolic dependency, and epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) sensitivity. We found that Plxna1 knockdown did not affect apoptosis but resulted in decreased cell proliferation and reductions in mRNA expression levels of proliferation-marker genes, such as Ccnd1 , Pcna , and Myc . In addition, we found decreased mRNA expression levels of glycolysis-associated genes, such as Pkm2 and Ldha , and decreased lactate production. In contrast, we found no changes in the mRNA expression levels of oxidative phosphorylation-associated genes, such as Cycs , Cox5a , and Atp5g1 . We found that Plxna1 knockdown conferred resistance to glucose starvation but increased cytotoxicity to oligomycin. Plxna1 or Sema3a knockdown caused an increased sensitivity to the EGFR-TKIs gefitinib and erlotinib, in Lewis lung carcinoma (LLC) cells. These findings demonstrate that PLXNA1 mediates the acquisition of malignant phenotypes induced by autocrine SEMA3A signaling.
📖 Papers frequently viewed together
4 Authors (Hong Jian, ..., Shun Lu)
37 Citations
18 Citations
References27
Newest
#1Takehiko Maeda (Niigata University of Pharmacy and Applied Life Sciences)H-Index: 20
#2Daisuke Yamada (Niigata University of Pharmacy and Applied Life Sciences)H-Index: 7
Last. Kohichi Kawahara (Niigata University of Pharmacy and Applied Life Sciences)H-Index: 12
view all 3 authors...
Abstract Cancer-induced bone pain (CIBP) is the most common pain arising from cancer and is inadequately managed with current standard therapeutics. While the etiology of CIBP remains to be fully elucidated, increasing evidence suggests that CIBP is uniquely complex. We tested whether semaphorin 3A (Sema3A) signals were involved in the development of CIBP in mice. The mouse model employed for CIBP – mice inoculated with Lewis lung carcinoma (LLC) cells injected into the femur intramedullary spac...
5 CitationsSource
#1Daisuke Yamada (Niigata University of Pharmacy and Applied Life Sciences)H-Index: 7
#2Kohichi Kawahara (Niigata University of Pharmacy and Applied Life Sciences)H-Index: 12
Last. Takehiko Maeda (Niigata University of Pharmacy and Applied Life Sciences)H-Index: 20
view all 3 authors...
Aberration of signaling pathways by genetic mutations or alterations in the surrounding tissue environments can result in tumor development or metastasis. However, signaling molecules responsible for these processes have not been completely elucidated. Here, we used mouse Lewis lung carcinoma cells (LLC) to explore the mechanism by which the oncogenic activity of Semaphorin3A (Sema3A) signaling is regulated. Sema3A knockdown by shRNA did not affect apoptosis, but decreased cell proliferation in ...
7 CitationsSource
#2Baocheng WangH-Index: 1
Last. Yunfeng YaoH-Index: 1
view all 4 authors...
Identifying activating EGFR mutations is a useful predictive strategy that helps select a population of advanced non-small-cell lung cancer (NSCLC) patients for treatment with EGFR tyrosine kinase inhibitors (TKIs). Patients with sensitizing EGFR mutations (predominantly an in-frame deletion in exon 19 and an L858R substitution) are highly responsive to first-generation EGFR TKIs, such as gefitinib and erlotinib, and show improved progression-free survival without serious side effects. However, ...
63 CitationsSource
#1Rebecca SorberH-Index: 6
#2Yaroslav TeperH-Index: 9
Last. Udo RudloffH-Index: 24
view all 13 authors...
The genetic profile of human pancreatic cancers harbors considerable heterogeneity, which suggests a possible explanation for the pronounced inefficacy of single therapies in this disease. This observation has led to a belief that custom therapies based on individual tumor profiles are necessary to more effectively treat pancreatic cancer. It has recently been discovered that axon guidance genes are affected by somatic structural variants in up to 25% of human pancreatic cancers. Thus far, howev...
15 CitationsSource
#1Lihua Huang (SYSU: Sun Yat-sen University)H-Index: 1
#2Liwu Fu (SYSU: Sun Yat-sen University)H-Index: 19
Since the discovery that non-small cell lung cancer (NSCLC) is driven by epidermal growth factor receptor (EGFR) mutations, the EGFR tyrosine kinase inhibitors (EGFR-TKIs, e.g., gefitinib and elrotinib) have been effectively used for clinical treatment. However, patients eventually develop drug resistance. Resistance to EGFR-TKIs is inevitable due to various mechanisms, such as the secondary mutation (T790M), activation of alternative pathways (c-Met, HGF, AXL), aberrance of the downstream pathw...
246 CitationsSource
#1Hironao Nakayama (Boston Children's Hospital)H-Index: 10
#2Sarah Bruneau (Boston Children's Hospital)H-Index: 7
Last. Michael Klagsbrun (Boston Children's Hospital)H-Index: 123
view all 6 authors...
Semaphorin 3F (SEMA3F) provides neuronal guidance cues via its ability to bind neuropilin 2 (NRP2) and Plexin A family molecules. Recent studies indicate that SEMA3F has biological effects in other cell types, however its mechanism(s) of function is poorly understood. Here, we analyze SEMA3F-NRP2 signaling responses in human endothelial, T cell and tumor cells using phosphokinase arrays, immunoprecipitation and Western blot analyses. Consistently, SEMA3F inhibits PI-3K and Akt activity, and resp...
34 CitationsSource
#1Thomas Worzfeld (MPG: Max Planck Society)H-Index: 20
#2Stefan Offermanns (Goethe University Frankfurt)H-Index: 100
Semaphorins — a group of cell-surface and secreted proteins whose effects are mediated by plexin receptors — are involved in intercellular communication in the nervous system, the immune system and during angiogenesis. Worzfeld and Offermanns summarize the pathological roles of semaphorins and plexins in cancer, bone diseases, immuno-inflammatory diseases and spinal cord injury, and discuss emerging strategies to therapeutically target these molecules.
183 CitationsSource
#1Keisuke Ito (Albert Einstein College of Medicine)H-Index: 34
#2Toshio Suda (Keio: Keio University)H-Index: 117
Studies of mouse models and advances in metabolomic analysis, particularly of haematopoietic stem cells, have revealed how metabolic cues from anaerobic glycolysis, bioenergetic signalling, the AKT–mTOR pathway, and Gln and fatty acid metabolism, affect the balance between stem cell self-renewal and differentiation. Understanding how metabolic pathways regulate fate decisions may be beneficial therapeutically.
622 CitationsSource
#1Andrea Casazza (Katholieke Universiteit Leuven)H-Index: 14
#2Damya Laoui (Vrije Universiteit Brussel)H-Index: 25
Last. Massimiliano Mazzone (Katholieke Universiteit Leuven)H-Index: 56
view all 10 authors...
Summary Recruitment of tumor-associated macrophages (TAMs) into avascular areas sustains tumor progression; however, the underlying guidance mechanisms are unknown. Here, we report that hypoxia-induced Semaphorin 3A (Sema3A) acts as an attractant for TAMs by triggering vascular endothelial growth factor receptor 1 phosphorylation through the associated holoreceptor, composed of Neuropilin-1 (Nrp1) and PlexinA1/PlexinA4. Importantly, whereas Nrp1 levels are downregulated in the hypoxic environmen...
345 CitationsSource
#1Takako Sano (Kanazawa University)H-Index: 6
#2Shinji Takeuchi (Kanazawa University)H-Index: 23
Last. Seiji Yano (Kanazawa University)H-Index: 56
view all 9 authors...
Acquired resistance to epidermal growth factor receptor–tyrosine kinase inhibitors (EGFR–TKIs), such as gefitinib and erlotinib, is a critical problem in the management of patients with EGFR mutant lung cancer. Several mechanisms have been reported involved in this acquired resistance, including hepatocyte growth factor (HGF) activation of an alternative pathway. PI3K and mTOR are downstream molecules of receptor tyrosine kinases, such as EGFR and Met, and are thought to be ideal targets for con...
28 CitationsSource
Cited By6
Newest
#1XiaoYing Gu (TMUCIH: Tianjin Medical University Cancer Institute and Hospital)H-Index: 1
#2Su Zhang (TMUCIH: Tianjin Medical University Cancer Institute and Hospital)H-Index: 2
Last. Ti Zhang (TMUCIH: Tianjin Medical University Cancer Institute and Hospital)H-Index: 10
view all 3 authors...
Vascular endothelial growth factor A (VEGFA) and its receptor VEGFR2 are the main targets of antiangiogenic therapies, and proteinuria is one of the common adverse events associated with the inhibition of the VEGFA/VEGFR2 pathway. The proteinuric kidney damage induced by VEGFR2 tyrosine kinase inhibitors (TKIs) is characterized by podocyte foot process effacement. TKI therapy promotes the formation of abnormal endothelial‒podocyte crosstalk, which plays a key role in TKI-induced podocyte injury ...
Source
Background. Colorectal cancer (CRC) is the third most common cancer in the world, and most of them are adenocarcinomas. CRC could be classified as colon adenocarcinoma (COAD) and rectum adenocarcinoma (READ) according to the original tumorigenesis position. Increasing evidences indicated that microRNAs (miRNAs) play an important role in the occurrence of multiple tumors. Methods. In this study, we firstly downloaded miRNA (COAD, 8 controls vs. 455 tumors; READ, 3 controls vs. 161 tumors) and mRN...
2 CitationsSource
#1Waleed S. Al Amri (University of Leeds)H-Index: 2
#2Diana E. Baxter (University of Leeds)H-Index: 3
Last. Thomas A. Hughes (University of Leeds)H-Index: 24
view all 7 authors...
PURPOSE More than a third of primary breast cancer patients are treated with cytotoxic chemotherapy, typically without guidance from predictive markers. Increased use of neoadjuvant chemotherapy provides opportunities for identification of molecules associated with treatment response, by comparing matched tumour samples before and after therapy. Our hypothesis was that somatic variants of increased prevalence after therapy promote resistance, while variants with reduced prevalence cause sensitiv...
5 CitationsSource
#1Minghua Bai (Xi'an Jiaotong University)H-Index: 1
#2Yiping Dong (Xi'an Jiaotong University)H-Index: 6
Last. Suxia Han (Xi'an Jiaotong University)H-Index: 18
view all 6 authors...
Esophageal cancer has recent shown a higher incidence but lower 5-year survival rate after normal clinical treatment in China. The aim of this study was to observe whether the inhibition of miR-196a affects esophageal cancer cell growth by modulating the nuclear factor-kappaB target gene and to detect the possible cooperative therapeutic effects on esophageal cancer by knocking down miR-196a expression combined with the specific inhibitor of nuclear factor-kappaB target genes. Thus, anti-miR-196...
1 CitationsSource
#1Weiwei Wang (Zhengzhou University)H-Index: 10
#2Zhihua Zhao (Zhengzhou University)H-Index: 8
Last. Xiang-Nan Li (Zhengzhou University)H-Index: 1
view all 9 authors...
Abstract Background MicroRNAs (miRNAs) are involved in oncogenesis of esophageal squamous cell carcinoma (ESCC). miR-134 is reported to have a tumour-suppressive role but its role in ESCC is not known. The present study was designed to examine whether miR-134 inhibits ESCC development and further explored relevant underlying mechanisms. Methods Differentially expressed genes related to ESCC were identified from microarray gene expression profiles. Immunohistochemical staining and RT-qRCR assays ...
14 CitationsSource
#1Michael J. Bray (Vandy: Vanderbilt University)H-Index: 6
#2Todd L. EdwardsH-Index: 47
Last. Digna R. Velez EdwardsH-Index: 31
view all 6 authors...
Objective To evaluate the relationship between genetic ancestry and uterine fibroid characteristics. Design Cross-sectional study. Setting Not applicable. Patient(s) A total of 609 African American participants with image- or surgery-confirmed fibroids in a biorepository at Vanderbilt University electronic health record biorepository and the Coronary Artery Risk Development in Young Adults studies were included. Intervention(s) None. Main Outcome Measure(s) Outcome measures include fibroid numbe...
6 CitationsSource